Two Sigma Advisers’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-37,092
| Closed | -$2.62K | – | 2636 |
|
2023
Q4 | $2.62K | Sell |
37,092
-394,100
| -91% | -$27.9K | ﹤0.01% | 2477 |
|
2023
Q3 | $56.8K | Sell |
431,192
-207,100
| -32% | -$27.3K | ﹤0.01% | 2268 |
|
2023
Q2 | $326K | Sell |
638,292
-883,100
| -58% | -$450K | ﹤0.01% | 1963 |
|
2023
Q1 | $958K | Sell |
1,521,392
-416,400
| -21% | -$262K | ﹤0.01% | 1654 |
|
2022
Q4 | $1.26M | Buy |
1,937,792
+628,300
| +48% | +$408K | ﹤0.01% | 1464 |
|
2022
Q3 | $2.25M | Sell |
1,309,492
-641,400
| -33% | -$1.1M | 0.01% | 1114 |
|
2022
Q2 | $2.42M | Sell |
1,950,892
-785,900
| -29% | -$974K | 0.01% | 1115 |
|
2022
Q1 | $1.79M | Sell |
2,736,792
-546,300
| -17% | -$356K | ﹤0.01% | 1326 |
|
2021
Q4 | $3.58M | Buy |
3,283,092
+2,221,700
| +209% | +$2.42M | 0.01% | 922 |
|
2021
Q3 | $1.93M | Buy |
1,061,392
+91,600
| +9% | +$167K | 0.01% | 1279 |
|
2021
Q2 | $2.56M | Buy |
969,792
+6,600
| +0.7% | +$17.4K | 0.01% | 1176 |
|
2021
Q1 | $3.47M | Buy |
963,192
+74,300
| +8% | +$267K | 0.01% | 1015 |
|
2020
Q4 | $2.24M | Buy |
888,892
+391,300
| +79% | +$986K | 0.01% | 1199 |
|
2020
Q3 | $1.25M | Buy |
497,592
+386,400
| +348% | +$974K | ﹤0.01% | 1399 |
|
2020
Q2 | $365K | Buy |
111,192
+27,400
| +33% | +$89.9K | ﹤0.01% | 2034 |
|
2020
Q1 | $205K | Buy |
+83,792
| New | +$205K | ﹤0.01% | 2163 |
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$19K | – | 2451 |
|
2018
Q4 | $19K | Buy |
+10,000
| New | +$19K | ﹤0.01% | 2313 |
|
2015
Q1 | – | Sell |
-19,201
| Closed | -$97K | – | 2165 |
|
2014
Q4 | $97K | Buy |
19,201
+6,300
| +49% | +$31.8K | ﹤0.01% | 2011 |
|
2014
Q3 | $34K | Sell |
12,901
-10,399
| -45% | -$27.4K | ﹤0.01% | 1726 |
|
2014
Q2 | $94K | Buy |
23,300
+10,499
| +82% | +$42.4K | ﹤0.01% | 1835 |
|
2014
Q1 | $59K | Buy |
+12,801
| New | +$59K | ﹤0.01% | 1679 |
|